On the development of the European S3 guidelines on the systemic treatment of psoriasis vulgaris

structure and challenges

D Pathirana, A Nast, A D Ormerod, N Reytan, P Saiag, C H Smith, P Spuls, B Rzany

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Abstract Background The development of evidence based guidelines is a demanding and time consuming process. Therefore it is important to share the knowledge and discuss the structure of these guidelines in detail. Objectives To present a method report on the development process of the European evidence based guidelines on the systemic treatment of psoriasis vulgaris with the aim to offer guidance to other guidelines groups with lesser experience and to critically appraise the methodology of the guidelines development process. Methods The guidelines are based on the previously evaluated literature from three European national evidence based guidelines and an additional systematic search and evaluation of new literature. Further steps included a structured consensus conference and a DELPHI procedure to develop the recommendations, as well as several internal and external reviews. All steps were coordinated by the Division of evidence based medicine in cooperation with a group of methodologists. Results A total of 114 studies were included, serving as base for the efficacy chapters of the intervention. The recommendations, based on the efficacy and the level of evidence of the included studies were discussed and finally consented by the guidelines group. After subsequent reviews the guidelines were presented to the European Dermatology Forum, European Academy of Dermatology and Venereology and Union Européenne des Médicins Spécialistes for approval and published in October 2009. Conclusion The development of European evidence based guidelines requires a coordinated structure which can be achieved by the integration of an experienced group of methodologists. Nevertheless further improvements are imaginable and might be considered for an update or other European evidence based guidelines.
Original languageEnglish
Pages (from-to)1458-1467
Number of pages10
JournalJEADV: Journal of the European Academy of Dermatology and Venereology
Volume24
Issue number12
Early online date9 Nov 2010
DOIs
Publication statusPublished - Dec 2010

Fingerprint

Psoriasis
Guidelines
Dermatology
Venereology
Evidence-Based Medicine

Keywords

  • European evidence-based guidelines
  • European S3 guidelines
  • psoriasis vulgaris
  • systemic therapy

Cite this

On the development of the European S3 guidelines on the systemic treatment of psoriasis vulgaris : structure and challenges. / Pathirana, D; Nast, A; Ormerod, A D; Reytan, N; Saiag, P; Smith, C H; Spuls, P; Rzany, B.

In: JEADV: Journal of the European Academy of Dermatology and Venereology, Vol. 24, No. 12, 12.2010, p. 1458-1467.

Research output: Contribution to journalArticle

Pathirana, D ; Nast, A ; Ormerod, A D ; Reytan, N ; Saiag, P ; Smith, C H ; Spuls, P ; Rzany, B. / On the development of the European S3 guidelines on the systemic treatment of psoriasis vulgaris : structure and challenges. In: JEADV: Journal of the European Academy of Dermatology and Venereology. 2010 ; Vol. 24, No. 12. pp. 1458-1467.
@article{32e879ab38e34e91a839844cd4c7e4c6,
title = "On the development of the European S3 guidelines on the systemic treatment of psoriasis vulgaris: structure and challenges",
abstract = "Abstract Background The development of evidence based guidelines is a demanding and time consuming process. Therefore it is important to share the knowledge and discuss the structure of these guidelines in detail. Objectives To present a method report on the development process of the European evidence based guidelines on the systemic treatment of psoriasis vulgaris with the aim to offer guidance to other guidelines groups with lesser experience and to critically appraise the methodology of the guidelines development process. Methods The guidelines are based on the previously evaluated literature from three European national evidence based guidelines and an additional systematic search and evaluation of new literature. Further steps included a structured consensus conference and a DELPHI procedure to develop the recommendations, as well as several internal and external reviews. All steps were coordinated by the Division of evidence based medicine in cooperation with a group of methodologists. Results A total of 114 studies were included, serving as base for the efficacy chapters of the intervention. The recommendations, based on the efficacy and the level of evidence of the included studies were discussed and finally consented by the guidelines group. After subsequent reviews the guidelines were presented to the European Dermatology Forum, European Academy of Dermatology and Venereology and Union Europ{\'e}enne des M{\'e}dicins Sp{\'e}cialistes for approval and published in October 2009. Conclusion The development of European evidence based guidelines requires a coordinated structure which can be achieved by the integration of an experienced group of methodologists. Nevertheless further improvements are imaginable and might be considered for an update or other European evidence based guidelines.",
keywords = "European evidence-based guidelines, European S3 guidelines, psoriasis vulgaris, systemic therapy",
author = "D Pathirana and A Nast and Ormerod, {A D} and N Reytan and P Saiag and Smith, {C H} and P Spuls and B Rzany",
year = "2010",
month = "12",
doi = "10.1111/j.1468-3083.2010.03671.x",
language = "English",
volume = "24",
pages = "1458--1467",
journal = "JEADV: Journal of the European Academy of Dermatology and Venereology",
issn = "0926-9959",
publisher = "Wiley-Blackwell",
number = "12",

}

TY - JOUR

T1 - On the development of the European S3 guidelines on the systemic treatment of psoriasis vulgaris

T2 - structure and challenges

AU - Pathirana, D

AU - Nast, A

AU - Ormerod, A D

AU - Reytan, N

AU - Saiag, P

AU - Smith, C H

AU - Spuls, P

AU - Rzany, B

PY - 2010/12

Y1 - 2010/12

N2 - Abstract Background The development of evidence based guidelines is a demanding and time consuming process. Therefore it is important to share the knowledge and discuss the structure of these guidelines in detail. Objectives To present a method report on the development process of the European evidence based guidelines on the systemic treatment of psoriasis vulgaris with the aim to offer guidance to other guidelines groups with lesser experience and to critically appraise the methodology of the guidelines development process. Methods The guidelines are based on the previously evaluated literature from three European national evidence based guidelines and an additional systematic search and evaluation of new literature. Further steps included a structured consensus conference and a DELPHI procedure to develop the recommendations, as well as several internal and external reviews. All steps were coordinated by the Division of evidence based medicine in cooperation with a group of methodologists. Results A total of 114 studies were included, serving as base for the efficacy chapters of the intervention. The recommendations, based on the efficacy and the level of evidence of the included studies were discussed and finally consented by the guidelines group. After subsequent reviews the guidelines were presented to the European Dermatology Forum, European Academy of Dermatology and Venereology and Union Européenne des Médicins Spécialistes for approval and published in October 2009. Conclusion The development of European evidence based guidelines requires a coordinated structure which can be achieved by the integration of an experienced group of methodologists. Nevertheless further improvements are imaginable and might be considered for an update or other European evidence based guidelines.

AB - Abstract Background The development of evidence based guidelines is a demanding and time consuming process. Therefore it is important to share the knowledge and discuss the structure of these guidelines in detail. Objectives To present a method report on the development process of the European evidence based guidelines on the systemic treatment of psoriasis vulgaris with the aim to offer guidance to other guidelines groups with lesser experience and to critically appraise the methodology of the guidelines development process. Methods The guidelines are based on the previously evaluated literature from three European national evidence based guidelines and an additional systematic search and evaluation of new literature. Further steps included a structured consensus conference and a DELPHI procedure to develop the recommendations, as well as several internal and external reviews. All steps were coordinated by the Division of evidence based medicine in cooperation with a group of methodologists. Results A total of 114 studies were included, serving as base for the efficacy chapters of the intervention. The recommendations, based on the efficacy and the level of evidence of the included studies were discussed and finally consented by the guidelines group. After subsequent reviews the guidelines were presented to the European Dermatology Forum, European Academy of Dermatology and Venereology and Union Européenne des Médicins Spécialistes for approval and published in October 2009. Conclusion The development of European evidence based guidelines requires a coordinated structure which can be achieved by the integration of an experienced group of methodologists. Nevertheless further improvements are imaginable and might be considered for an update or other European evidence based guidelines.

KW - European evidence-based guidelines

KW - European S3 guidelines

KW - psoriasis vulgaris

KW - systemic therapy

U2 - 10.1111/j.1468-3083.2010.03671.x

DO - 10.1111/j.1468-3083.2010.03671.x

M3 - Article

VL - 24

SP - 1458

EP - 1467

JO - JEADV: Journal of the European Academy of Dermatology and Venereology

JF - JEADV: Journal of the European Academy of Dermatology and Venereology

SN - 0926-9959

IS - 12

ER -